Hypochloremia and diuretic resistance in heart failure

Circulation: Heart Failure

Volumn 9, Issue 8, 2016, Pages

  Hanberg, Jennifer S ^a   Rao, Veena ^a   Ter Maaten, Jozine M ^a,b   Laur, Olga ^a   Brisco, Meredith A ^c   Wilson, F Perry ^a,d   Grodin, Justin L ^e   Assefa, Mahlet ^a   Broughton, J Samuel ^a   Planavsky, Noah J ^f   Ahmad, Tariq ^a   Bellumkonda, Lavanya ^a   Tang, W H Wilson ^e   Parikh, Chirag R ^a   Testani, Jeffrey M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f YALE UNIVERSITY   (United States)

Author keywords

cardiorenal syndrome; chloride; diuretics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; BUMETANIDE; CHLORIDE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; LYSINE CHLORIDE; RENIN; SODIUM; TORASEMIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FUROSEMIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIORENAL SYNDROME; CHLORIDE BLOOD LEVEL; CLINICAL EVALUATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DIURESIS; DIURETIC RESISTANCE; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEART FAILURE; HEMOCONCENTRATION; HUMAN; HYPOCHLOREMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MINERAL SUPPLEMENTATION; OBSERVATIONAL STUDY; ODDS RATIO; OUTPATIENT; PILOT STUDY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENIN RELEASE; SODIUM BLOOD LEVEL; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; URINE OSMOLALITY; WEIGHT REDUCTION; BLOOD; CLINICAL TRIAL; CONNECTICUT; CROSS-SECTIONAL STUDY; DOWN REGULATION; DRUG EFFECTS; DRUG RESISTANCE; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CHLORIDES; CONNECTICUT; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; DRUG RESISTANCE; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; KIDNEY; MALE; MIDDLE AGED; ODDS RATIO; PILOT PROJECTS; PROSPECTIVE STUDIES; RENIN; RISK FACTORS; SODIUM; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84983541251     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.003180     Document Type: Article

References (28)

1. O'Connor CM, Ahmad T, The role of sodium and chloride in heart failure: does it take two to tango? J Am Coll Cardiol 2015 66 667 669. doi: 10.1016/j.jacc.2015.05.070
2. Gheorghiade M, Filippatos G, De Luca L, Burnett J, Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 2006 119 12 suppl 1 S3 S10. doi: 10.1016/j.amjmed.2006.09.011
3. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 62 e147 e239. doi: 10.1016/j.jacc.2013.05.019
4. Gandhi S, Mosleh W, Myers RB, Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. Int J Cardiol 2014 173 139 145. doi: 10.1016/j.ijcard.2014.03.020
5. De Vecchis R, Esposito C, Ariano C, Cantatrione S, Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: a meta-analysis of the literature. Herz 2015 40 423 435. doi: 10.1007/s00059-013-4041-6
6. Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L, Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med 2013 173 1058 1064. doi: 10.1001/jamainternmed.2013.552
7. Doukky R, Avery E, Mangla A, Collado FM, Ibrahim Z, Poulin MF, Richardson D, Powell LH, Impact of dietary sodium restriction on heart failure outcomes. JACC Heart Fail 2016 4 24 35. doi: 10.1016/j.jchf.2015.08.007
8. Miller WL, Borgeson DD, Grantham JA, Luchner A, Redfield MM, Burnett JC Jr, Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. Eur J Heart Fail 2015 17 144 150
9. Berend K, van Hulsteijn LH, Gans RO, Chloride: the queen of electrolytes? Eur J Intern Med 2012 23 203 211. doi: 10.1016/j.ejim.2011.11.013
10. Wesson DE, Glomerular filtration effects of acute volume expansion: importance of chloride. Kidney Int 1987 32 238 245
11. Briggs JP, Schnermann JB, Whys and wherefores of juxtaglomerular apparatus function. Kidney Int 1996 49 1724 1726
12. Briggs J, The macula densa sensing mechanism for tubuloglomerular feedback. Fed Proc 1981 40 99 103
13. Kotchen TA, Welch WJ, Lorenz JN, Ott CE, Renal tubular chloride and renin release. J Lab Clin Med 1987 110 533 540
14. Piala AT, Moon TM, Akella R, He H, Cobb MH, Goldsmith EJ, Chloride sensing by WNK1 involves inhibition of autophosphorylation. Sci Signal 2014 7 ra41. doi: 10.1126/scisignal.2005050
15. Ponce-Coria J, San-Cristobal P, Kahle KT, Vazquez N, Pacheco-Alvarez D, de Los Heros P, Juárez P, Muñoz E, Michel G, Bobadilla NA, Gimenez I, Lifton RP, Hebert SC, Gamba G, Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci USA 2008 105 8458 8463. doi: 10.1073/pnas.0802966105
16. Subramanya AR, Yang CL, McCormick JA, Ellison DH, WNK kinases regulate sodium chloride and potassium transport by the aldosterone-sensitive distal nephron. Kidney Int 2006 70 630 634. doi: 10.1038/sj.ki.5001634
17. Grodin JL, Simon J, Hachamovitch R, Wu Y, Jackson G, Halkar M, Starling RC, Testani JM, Tang WH, Prognostic role of serum chloride levels in acute decompensated heart failure. J Am Coll Cardiol 2015 66 659 666. doi: 10.1016/j.jacc.2015.06.007
18. Grodin JL, Verbrugge FH, Ellis SG, Mullens W, Testani JM, Tang WH, Importance of abnormal chloride homeostasis in stable chronic heart failure. Circ Heart Fail 2016 9 e002453. doi: 10.1161/CIRCHEARTFAILURE.115.002453
19. Testani JM, Hanberg JS, Arroyo JP, Brisco MA, Ter Maaten JM, Wilson FP, Bellumkonda L, Jacoby D, Tang WH, Parikh CR, Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail 2016 18 660 668. doi: 10.1002/ejhf.477
20. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC, Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995 57 601 609. doi: 10.1016/0009-9236(95)90222-8
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 150 604 612
22. Koomans HA, Boer WH, Dorhout Mees EJ, Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989 36 2 12
23. Brenner BM, Rector FC, Brenner and Rector's the Kidney 2008 Philadelphia Saunders Elsevier
24. Ward A, Heel RC, Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984 28 426 464
25. Yunos NM, Bellomo R, Story D, Kellum J, Bench-to-bedside review: chloride in critical illness. Crit Care 2010 14 226. doi: 10.1186/cc9052
26. Adrogué HJ, Madias NE, Hyponatremia. N Engl J Med 2000 342 1581 1589. doi: 10.1056/NEJM200005253422107
27. Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH, Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 2013 62 516 524. doi: 10.1016/j.jacc.2013.05.027
28. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C, Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007 297 1319 1331. doi: 10.1001/jama.297.12.1319